2nd Edition: Diagnosis, Treatment and Rehabilitation in Health Services for Patients with Intellectual Disability and Mental Health Problems

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Mental Health".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 1842

Special Issue Editor


E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues,

This new Special Issue will be a continuation of the first edition published from 2020 to 2022 in the International Journal of Environmental Research and Public Health. Data regarding the frequency of the coexistence of intellectual disability and other mental disorders provided by various sources are not consistent due to differences in research methodology and the use of different diagnostic criteria and therapeutic strategies. This problem can affect people throughout childhood, adolescence, adulthood, and old age. The disorders comorbid with intellectual disability include, among others, depression, anxiety disorders, dementia, schizophrenia and other psychotic disorders, ADHD, and autism. Persons with intellectual disability also present specific comorbidities in their somatic health, such as thyroid diseases, cardiovascular disorders, and endocrinological disorders, which may have non-specific symptoms and affect the patients’ psychological well-being. Recommendations for the treatment of the abovementioned disorders in persons with intellectual disability require the creation of interdisciplinary teams employing various specialists, monitoring both mental and somatic health, and checking the indications, doses, effectiveness, and side effects of drugs. The use of psychopharmacological agents specific to a particular illness is proposed for the treatment of comorbid mental disorders. There is also a need for a wider use of diagnostic questionnaires developed for this group of patients. Some authors also postulate the need to introduce new diagnostic guidelines and criteria. It is also very important to increase the availability of modern methods of pharmacological treatment, including the use of second-generation antipsychotic drugs. We should also introduce methods that use new technologies, such as telemedicine and virtual reality. In this Special Issue we would also like to focus on the treatment of those somatic comorbidities which are specific to intellectual disability and have a high influence on patients’ quality of life.

You may choose our Joint Special Issue in International Journal of Environmental Research and Public Health.

Prof. Dr. Krzysztof Krysta
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • intellectual disability
  • psychiatric disorders
  • comorbidity
  • diagnostic guidelines
  • treatment recommendations
  • health services

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

16 pages, 968 KiB  
Article
Validation of the Scale of Emotional Development-Short (SED-S) in Healthy Adults with an Intellectual Disability
by Theresa Meinecke, Miriam Flachsmeyer and Tanja Sappok
J. Clin. Med. 2024, 13(17), 5113; https://doi.org/10.3390/jcm13175113 - 28 Aug 2024
Viewed by 931
Abstract
Background: The Scale of Emotional Development-Short (SED-S) assesses the level of emotional development (ED) of persons with intellectual disability (ID) in eight domains across five stages with reference ages from 0 to 12 years. The aim of this study was to apply and [...] Read more.
Background: The Scale of Emotional Development-Short (SED-S) assesses the level of emotional development (ED) of persons with intellectual disability (ID) in eight domains across five stages with reference ages from 0 to 12 years. The aim of this study was to apply and validate the SED-S in a sample of healthy adults with ID. Method: Eighty-three mentally healthy adults with ID were assessed using the SED-S. Factor analysis, Cronbach’s alpha, and correlational analyses were used to test the scale’s internal structure and associations. Results: The results showed that the eight-domain structure of the SED-S is supported by strong inter-domain correlations, a high Cronbach’s alpha, and a one-factor confirmatory factor analysis. The SED-S was associated with the severity of ID but not with age or gender. Conclusions: The SED-S can be used in non-clinical settings to better understand and meet the emotional needs of adults with ID. Full article
Show Figures

Figure 1

Other

Jump to: Research

22 pages, 1578 KiB  
Systematic Review
Light Therapy for Older People with Depressive Symptoms: Systematic Review and Meta-Analysis
by Ji-Woo Seok and Jung-Dae Kim
J. Clin. Med. 2024, 13(22), 6982; https://doi.org/10.3390/jcm13226982 - 20 Nov 2024
Viewed by 337
Abstract
Background/Objectives: Light therapy has emerged as a promising non-pharmacological treatment for depressive symptoms. This meta-analysis aims to evaluate the effectiveness of light therapy specifically for depressive symptoms in elderly populations, with a focus on how different light intensities and spectra influence treatment outcomes. [...] Read more.
Background/Objectives: Light therapy has emerged as a promising non-pharmacological treatment for depressive symptoms. This meta-analysis aims to evaluate the effectiveness of light therapy specifically for depressive symptoms in elderly populations, with a focus on how different light intensities and spectra influence treatment outcomes. Methods: A systematic search targeting studies on light therapy for depressive symptoms in older adults was performed across multiple databases, including PubMed, Google Scholar, PsycINFO, and EMBASE, covering studies from database inception until July 2024. A total of 565 records were identified, with 461 studies remaining after removing duplicates. Following the screening of titles and abstracts, 54 studies underwent full-text review, resulting in the inclusion of 22 studies with a total of 1290 participants (687 in the intervention group and 603 in the control group). Results: The overall effect size for light therapy on depressive symptoms was moderate (Hedges’ g = 0.525, p < 0.001). Higher light intensities (10,000 lux and above) demonstrated significantly greater effectiveness compared to lower intensities. White light had the most substantial effect, while bluish light showed moderate efficacy. Significant heterogeneity was observed across studies (I2 = 80.459%), indicating variability in treatment outcomes based on study design, intensity, and light spectrum. Conclusions: This meta-analysis confirms that light therapy is an effective treatment for reducing depressive symptoms in older adults, particularly at higher intensities and with specific light spectra such as white light. Given the heterogeneity in results, future research should focus on optimizing treatment parameters to enhance clinical outcomes within this population. Full article
Show Figures

Figure 1

Back to TopTop